Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Originally developed in Russia, it is widely used in nootropic and neuroprotection research, with studies investigating its effect on BDNF expression and cognitive performance markers in preclinical models.
A mitochondrial-derived peptide studied for its influence on metabolic homeostasis.
A C-terminal tripeptide fragment of alpha-MSH studied for anti-inflammatory signaling.
A synthetic melanocortin agonist derived from Melanotan II, studied in libido-pathway research.
Veyra Peptides supplies research compounds for laboratory and in-vitro research use only. Products are not intended for human or veterinary consumption, diagnostic use, or in-vivo application of any kind. By entering, you confirm you are at least 21 years of age and are acquiring these materials solely for qualified research purposes.
I do not agree, take me back